- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/395 - AntibodiesImmunoglobulinsImmune serum, e.g. antilymphocytic serum
Patent holdings for IPC class A61K 39/395
Total number of patents in this class: 45750
10-year publication summary
|
2503
|
2825
|
2759
|
2778
|
3001
|
2921
|
2726
|
2531
|
2345
|
84
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Genentech, Inc. | 4014 |
867 |
| Regeneron Pharmaceuticals, Inc. | 4458 |
770 |
| Novartis AG | 10506 |
571 |
| Amgen Inc. | 4275 |
531 |
| F. Hoffmann-La Roche AG | 7896 |
490 |
| Chugai Seiyaku Kabushiki Kaisha | 1391 |
454 |
| The Regents of the University of California | 20324 |
451 |
| Janssen Biotech, Inc. | 1597 |
416 |
| Bristol-myers Squibb Company | 4793 |
374 |
| Hoffmann-La Roche Inc. | 3567 |
315 |
| The Board of Trustees of the Leland Stanford Junior University | 6553 |
286 |
| Memorial Sloan-Kettering Cancer Center | 1980 |
284 |
| Dana-Farber Cancer Institute, Inc. | 2620 |
265 |
| Board of Regents, The University of Texas System | 5966 |
255 |
| The Johns Hopkins University | 5762 |
235 |
| Daiichi Sankyo Company, Limited | 1877 |
216 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3361 |
214 |
| Eli Lilly and Company | 3949 |
211 |
| Pfizer Inc. | 3391 |
202 |
| The Trustees of the University of Pennsylvania | 4380 |
198 |
| Other owners | 38145 |